Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis
about
Immune Cell Regulatory Pathways Unexplored as Host-Directed Therapeutic Targets for Mycobacterium tuberculosis: An Opportunity to Apply Precision Medicine Innovations to Infectious DiseasesThe Tyrosine Kinase Inhibitor Gefitinib Restricts Mycobacterium tuberculosis Growth through Increased Lysosomal Biogenesis and Modulation of Cytokine Signaling.Suppress for Success: A JAK Inhibitor for Adjunct Therapy of TuberculosisThe Troika Host-Pathogen-Extrinsic Factors in Tuberculosis: Modulating Inflammation and Clinical Outcomes.
P2860
Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis
@ast
Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis
@en
type
label
Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis
@ast
Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis
@en
prefLabel
Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis
@ast
Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis
@en
P2093
P2860
P1433
P1476
Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis
@en
P2093
Flabou Bougoudogo
Laurene Cheung
Mamoudou Maiga
Mariama C Maiga
Shaaretha Pelly
Shichun Lun
William R Bishai
P2860
P304
P356
10.1016/J.EBIOM.2015.07.014
P577
2015-07-14T00:00:00Z